Search Within
SAB4700108
Applied Filters:
Keyword:'SAB4700108'
Showing 1-7 of 7 results for "SAB4700108" within Papers
The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity.
Tedder TF
Immunity, 6, 107-118 (1997)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
Kochenderfer JN
Blood, 119, 2709-2720 (2012)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.
Wang K
Experimental Hematology & Oncology, 1 (2012)
The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT and Carter RH.
Annual Review of Immunology, 127-149 (1995)
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A
Journal of Immunology, 138, 2793-2799 (1987)
Yan Hu et al.
EMBO reports, 22(7), e52481-e52481 (2021-06-15)
Receptor activator of NF-κB ligand (RANKL) is essential for osteoclast formation and bone remodeling. Nevertheless, the cellular source of RANKL for osteoclastogenesis has not been fully uncovered. Different from peripheral adipose tissue, bone marrow (BM) adipose lineage cells originate from
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE
Journal of Immunology, 149, 2841-2850 (1992)
Page 1 of 1